StockWatch
·
Medical/Dental Instruments
Management ChangeOct 8, 2026, 07:21 AM

AngioDynamics Appoints Eric Honroth as New CEO, Effective Nov 2

AI Summary

AngioDynamics, Inc. announced the appointment of Eric Honroth as its new President and Chief Executive Officer, effective November 2, 2026. Mr. Honroth will also join the Board of Directors. He succeeds James C. Clemmer, who will retire from his CEO role and the Board on the same date but will remain as a consultant to ensure a smooth transition. Mr. Honroth's compensation package includes a base salary of $735,000, a target annual bonus of 95% of base salary, a $350,000 sign-on bonus, and significant long-term incentive awards.

Key Highlights

  • Eric Honroth appointed President and CEO of AngioDynamics, effective November 2, 2026.
  • Eric Honroth also appointed to the Board of Directors.
  • James C. Clemmer to retire as CEO and depart the Board on November 2, 2026.
  • Mr. Honroth's employment agreement includes a base salary of $735,000.
  • Mr. Honroth eligible for a target annual bonus of 95% of base salary.
  • Mr. Honroth to receive a sign-on bonus of $350,000.
  • Mr. Honroth to receive long-term incentive awards valued at $1,487,116 and a $450,000 restricted stock unit award.
  • James C. Clemmer to remain as a consultant for a smooth transition.